Stock Ratings / Health Care / BTI / financials

MO (89) PM (81) DFTX (52) RGC (38) ⌘ Pro Terminal →

British American Tobacco Industries p.l.c. ADR (BTI) Revenue-to-Profit Sankey Flow & SEC XBRL Financials

$61.52 +0.74% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $61.49

British American Tobacco Industries p.l.c. ADR (BTI) carries a Roarable Rating of C+ (Hold) with 66/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

📊 Historical Track Record: Scores of 66/100 (C+) historically posted market-perform odds over rolling 90-day windows (+1.4% avg 90D alpha vs SPY) →

ROARABLE C+ • HOLD / WATCH Cap $131.93B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on BTI Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is BTI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-02, British American Tobacco Industries p.l.c. ADR (NYSE: BTI) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 66/100 at a spot price of $61.52 (+0.74% 1D, market cap $131.93B). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 14/20, Executive Insider Alignment 16/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 12/20. Across 1016 tracked Health Care issuers, BTI ranks #114 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does BTI compare to MO and PM in the Health Care sector?

▼

Within the Health Care sector (Medicinal Chemicals and Botanical Products), BTI carries a Roarable C+ (66/100 RQD), trailing P/E of 32.8x, gross margin of —, and ROIC of 9.9%. By comparison, MO (Altria Group Inc.) holds a A grade (89/100 RQD, P/E 18.4x, ROIC 48.4%, cap $128.15B) and PM (Philip Morris International Inc) posts a A- grade (81/100 RQD, P/E 28.6x, ROIC 45.3%, cap $324.98B). Among the 5-stock peer group, MO leads on earnings multiple (18.4x) while MO leads on capital efficiency (48.4% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for BTI?

▼

For British American Tobacco Industries p.l.c. ADR (BTI), key quantitative strengths include Clean SEC annual filing review with no major hidden accounting time-bombs. and sector rank #114 in Health Care, while primary risk factors center on Broader market pullbacks can still drag down strong stocks in the short run. and implied 5-year growth hurdle of 25.3%/yr. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $61.48 (-0.06%)🧬 Cannibal Buyback (-1.24% YoY Shares)⚙️ Cash Engine: 11/20 (D+) • 15.8% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 66/100 (C+) historically posted market-perform odds over rolling 90-day windows (+1.4% avg 90D alpha vs SPY • 56.0% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERHOLD / WATCH • C+

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw C · Rk B

Each axis scored 0–20

12M PRICE TARGET CONE+3.6% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for BTI)Realized 20D OHLCV Swing Band: ±3.2%

Deterministic 5-Pillar Attribution (66/100 Composite)

🔍 WHY BTI SCORES 66/100 (C+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+16/20 pts (24% of score)

Altman Z-Score 3.74 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▲ #2 Bullish Driver: Whale & Options Positioning+14/20 pts (21% of score)

20D Institutional Volume Accumulation (±3.2% realized swing band)

▼ #1 Drag / Risk Factor: Cash Engine Quality11/20 pts (-9 pt drag)

Capital intensity & 13.9% operating margin leave 9 pts on the table

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C$55.65+6.2% Next Q

Q2 (-2Q)

Grade C$59.11+1.2% Next Q

Q3 (-1Q)

Grade C+$59.83+2.8% Next Q

Current

Grade C+$61.52+1.4% Hist 90D α

Trajectory: C (58) → C+ (66)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the BTI Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 66/100 (C+) score, BTI faces multiple-compression risk if 32.8x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Broader market pullbacks can still drag down strong stocks in the short run.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-1.24% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($56.68) or 200D SMA ($59.17) invalidates the momentum regime and cuts Target Base ($63.73) toward Bear Floor ($49.71).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $BTI• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “BTI Beats Next Quarter EPS Consensus (Upcoming Quarter) & Holds Above 200D SMA”

YES 66%NO 34%Trade / Inspect Odds →

VISUAL REVENUE-TO-PROFIT SANKEY WATERFALL • Trailing 12 Months

How BTI Turns Every Dollar of Sales Into Real Bottom-Line Profit

Free Cash Flow:$2.92B (15.8% FCF Margin)

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring BTI)

✓Walkthrough of BTI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

BTI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +5.43%⚡ TESTING RESISTANCE

2026-11-02O $59.80H $61.52L $59.80C $61.52VOL 3.98M

RES: $62.46SUP: $50.31SMA50: $56.68SMA200: $59.17

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

BTI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 BTI Butterfly Map → + Track BTI →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

25.3%/yr Implied 5Y Growth

vs. 0.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on BTI today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for BTI. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for BTI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (BTI)

Health Care Rank #114 of 1016 ⚔️ MO vs BTI Full Matrix →

1. Head-to-Head Health Care Peer Comparison (BTI vs. MO, PM, DFTX, RGC)

Industry: Medicinal Chemicals and Botanical Products (24 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, British American Tobacco Industries p.l.c. ADR (BTI) ranks #114 by composite RQD confidence (66/100, grade C+) and #16 by equity capitalization ($131.93B). Within this direct 5-issuer industry benchmark cohort, MO leads on earnings valuation at 18.4x trailing P/E, while MO leads on capital efficiency and profitability with 48.4% ROIC and 62.5% gross margin. MO currently holds the highest overall quantitative score in the immediate peer group at 89/100 (A) compared with BTI at 66/100 (C+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
BTI ACTIVE British American Tobacco Industries p.l.c. ADR	C+	66/100	32.8x	—	9.9%	+0.74%	$131.93B	Benchmark Subject
MO Altria Group Inc.	A	89/100	18.4x	62.5%	48.4%	+1.67%	$128.15B	/mo-vs-bti →
PM Philip Morris International Inc	A-	81/100	28.6x	67.1%	45.3%	+0.14%	$324.98B	/pm-vs-bti →
DFTX Definium Therapeutics Inc.	D+	52/100	—	—	-32.2%	-4.29%	$5.10B	/dftx-vs-bti →
RGC Regencell Bioscience Holdings Limited	D-	38/100	—	—	—	-2.19%	$3.40B	/rgc-vs-bti →

2. BTI Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics

TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOT

British American Tobacco Industries p.l.c. ADR (BTI) operates in Medicinal Chemicals and Botanical Products (Health Care) with an equity capitalization of $131.93B, trailing P/E of 32.8x, forward P/E of 30.5x, and EV/EBITDA of 21.0x. Operating profitability registers a gross margin of —, operating margin of 13.9%, net profit margin of 10.9%, ROIC of 9.9%, and free cash flow yield of 2.21%, alongside an Altman Z-Score of 3.74 and Piotroski F-Score of 7/9.

3. BTI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is BTI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does BTI compare to MO and PM in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for BTI?

Where is BTI trading relative to its 50-day, 200-day, and 52-week technical levels?

BTI last traded at $61.52 (+0.74% on volume of 4,821,500 shares), positioning the stock +8.54% above its 50-day simple moving average ($56.68) and +3.97% above its 200-day simple moving average ($59.17). Across its 52-week range of $51.80 to $67.30, BTI sits at the 62.7% percentile with a 14-day RSI of 65.7 (BULLISH MOMENTUM) and an implied next-earnings move of ±3.2% ($59.55 to $63.49).

BTI Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

How profitable is British American Tobacco Industries p.l.c. ADR (BTI)?

In Trailing 12 Months, BTI converted $18.5B of revenue into a 52% gross margin, 13.9% operating margin, and $2.9B in free cash flow (15.8% FCF margin).

Direct Sub-Reports: BTI RQD Cockpit BTI 12M Forecast BTI Earnings & Move BTI Dividends & DRIP BTI Insiders & 13F BTI Whale Options BTI Profit Sankey BTI News & Why

ROARABLE RATING BRIEF • RQD 66/100 (C+) ✓ STAGE-C NUMBER FIREWALL VERIFIED

BTI — British American Tobacco Industries p.l.c. ADR: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5

As of: 2026-11-02T14:08:04Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, BTI scores 66 out of 100 (letter grade C+, verdict "Roarable Hold — Upper Neutral / Watch for Breakout"). The five pillar scores are:

Fundamental Cash Engine: 11 / 20. Per the Roarable RQD rating, this pillar reflects ROIC of 9.9% and an FCF yield of 2.21%. Implication: returns on capital are positive but moderate, and the cash yield at the current price is thin, which limits the margin of safety on valuation.
Whale 13F Flow: 14 / 20. Per the Roarable RQD rating, this pillar reflects institutional accumulation and options positioning. Implication: institutional positioning is a modest supportive factor, though the underlying 13F detail is not itemized in the source data.
Insider Conviction: 12 / 20. Per the Roarable RQD rating, this pillar reflects SEC Form 4 and Congressional PTR cluster flow. Implication: insider signals are neutral-to-mildly-supportive without a strong conviction signal.
Macro Regime Fit: 13 / 20. Per the Roarable RQD rating, this pillar reflects a beta of 1.05 and sector sensitivity. Implication: the stock moves roughly in line with the market, so it neither cushions nor amplifies broad swings meaningfully.
Forensic Balance Sheet: 16 / 20. Per the Roarable RQD rating, this pillar reflects Altman Z 3.74, Piotroski F 7/9, and Debt/Equity 0.39. Implication: this is the strongest pillar, indicating balance sheet resilience.

Taken together, the rating points to a stock whose balance sheet is its strongest feature, while valuation (trailing P/E of 32.8 against a 2.21% FCF yield) and moderate returns temper upside. The "Watch for Breakout" label suggests the rating framework sees potential for re-rating, but the source data does not specify the trigger.

Snapshot

Price	Market Cap	P/E (TTM)	Forward P/E	EV/EBITDA	EPS (TTM)	Dividend Yield	Beta	52-Wk Range	ROIC %
61.07	$131.93B	32.8	30.5	21	1.86	0%	1.05	$51.8 - $67.3	9.9%

Business

Per the profile, British American Tobacco Industries p.l.c. Common Stock ADR (BTI) is a NYSE-listed issuer in the Health Care sector, within the Medicinal Chemicals and Botanical Products industry. Per the profile, its market capitalization is $131.9B. Not available in source data: product lines, customer segments, and revenue model details.

Open Questions

What are the revenue, earnings, and cash flow figures by period, since the financials section is empty?
What drives the gross margin figure of 0% in the market data, and is it a reporting artifact?
What specific institutional, insider, or Congressional transactions make up the whale and insider pillar scores?
What catalyst would trigger the "Watch for Breakout" condition the verdict label references?
What analyst consensus and price targets exist, given that no analyst data was supplied?

BTI Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for British American Tobacco Industries p.l.c. ADR (BTI) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to BTI Debate Forum (3) ↓

🟡 MARKET WIRE SeekingAlpha • 2d ago

2 High-Yield Retirement Staples That Just Became Easier To Buy

Q3 earnings season made two strategic income holdings even more attractive, but for opposite reasons. Discover more in this analysis.

Read Full Source ↗

🔴 RISK WATCH Yahoo • 3d ago

Icahn Enterprises and 5 Other High-Yield Stocks With Dividend Safety Concerns

A 38% yield sounds like a jackpot until you see what is actually funding it. Six popular income stocks are flashing warning signs that most dividend investors overlook until a cut hits their account.

Read Full Source ↗

🟡 MARKET WIRE Benzinga • 3d ago

FDA Authorizes Marketing of 24 Velo Nicotine Pouches

https://www.fda.gov/tobacco-products/ctp-newsroom/fda-authorizes-marketing-24-velo-nicotine-pouches

Read Full Source ↗

🟢 CATALYST Yahoo • 4d ago

Tobacco, Beer and Spirits: 4 Sin Stocks Paying Dividends Up to 5.5%

Tobacco, beer, and spirits stocks promise reliable income through any downturn, but the safety picture behind each payout varies so widely that picking the wrong one could cost you more than the dividend is worth.

Read Full Source ↗

🟡 MARKET WIRE Benzinga • 4d ago

UK Department Of Health And Social Care Extends Under-18 Sales Ban To Nicotine Products And All Vapes

https://www.gov.uk/government/news/under-18-sales-ban-extended-to-nicotine-products-and-all-vapes

Read Full Source ↗

🟡 MARKET WIRE Fintel • 5d ago

British American Tobacco p.l.c. Announces Board and Committee Changes

Read Full Source ↗

🟡 MARKET WIRE SeekingAlpha • 5d ago

First Eagle Global Fund Q3 202 Portfolio Update

Global Fund A Shares (without sales charge) posted a return of 2.10% in third quarter 2026. Read more here.

Read Full Source ↗

🟢 CATALYST Yahoo • 6d ago

4 Big-Name Dividend Stocks Paying Yields Most Blue Chips Can’t Match

Four household names spread across pipelines, tobacco, banking, and consumer staples are paying yields that most blue chips never come close to, but a big yield number means nothing if the cash behind it runs dry.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

BTI Bull vs. Bear Conversation Board — What's Your Call at $61.52?

🐂 50% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON BTI 🐻 50% BEARISH CONVICTION

RO RoarDesk_Moderator Roarable Research Desk ⚖️ DEBATE HOST 🎯 Target: $65.96 (+8.0%)

📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is BTI (C+ • RQD 66/100) a Buy at $61.07?

Welcome to the BTI (British American Tobacco Industries p.l.c. ADR) Roar Pit. Current RQD Composite is 66/100 (Roarable Hold — Upper Neutral / Watch for Breakout) in Medicinal Chemicals and Botanical Products. Bulls point to operating leverage and sector positioning, while bears focus on valuation multiple compression (32.8x trailing P/E). Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

RI RiskArb_Desk Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $50.69 (-17.0%)

Spot @ $61.07

Pump the brakes on BTI — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on BTI, but look at what you are paying: 32.8x trailing P/E with tightening sector spreads. Unless British American Tobacco Industries p.l.c. ADR expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

DE DeltaGamma_99 Verified K Arena Trader 🐂 BULLISH 🎯 Target: $76.34 (+25.0%)

Spot @ $61.07

BTI cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on BTI, the market is fixating on short-term headline noise in Medicinal Chemicals and Botanical Products and ignoring the balance sheet and cash flow trajectory. At $61.07 (52-wk range $51.80 - $67.30), any beat on forward guidance forces shorts and underweight funds to chase.